Fatal reactivation of hepatitis B with temozolomide.
Grewal
Jai
J
Dellinger
Caryl A
CA
Yung
W K A
WK
D000368:Aged; D000927:Anticonvulsants / Q000627:therapeutic use; D018906:Antineoplastic Agents, Alkylating / Q000009:adverse effects*; D001932:Brain Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D003606:Dacarbazine / Q000009:adverse effects / Q000031:analogs & derivatives*; D017809:Fatal Outcome; D005260:Female; D005909:Glioblastoma / Q000188:drug therapy / Q000532:radiotherapy; D006509:Hepatitis B; D006515:Hepatitis B virus / Q000502:physiology*; D006801:Humans; D000077204:Temozolomide; D013702:Temporal Lobe; D014635:Valproic Acid / Q000627:therapeutic use; D019562:Viral Load; D014775:Virus Activation / Q000187:drug effects*
D000927:Anticonvulsants; D018906:Antineoplastic Agents, Alkylating; D014635:Valproic Acid; D003606:Dacarbazine; D000077204:Temozolomide